Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kaiwei refers to a group of traditional Chinese medicine (TCM) products and formulations used primarily for digestive health. The most common forms include "Kaiwei Lipi Pills," "Xingpi Kaiwei Granules," and "KAI WEI JIAN PI WAN." These are typically brown honey pills or granules administered orally. They are indicated for symptoms such as food retention due to spleen deficiency, poor appetite, abdominal distension, and indigestion. The mechanism of action is based on TCM principles—primarily strengthening the spleen and aiding digestion rather than targeting specific molecular pathways as in Western pharmaceuticals[1][2][9]. There is no evidence that "Kaiwei" refers to a single pharmaceutical agent or small molecule drug; instead, it represents a class of herbal/dietary supplement products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kaiwei.